Barclays PLC Has $180,000 Stock Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Barclays PLC lessened its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 32.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,664 shares of the company’s stock after selling 3,626 shares during the quarter. Barclays PLC’s holdings in Semler Scientific were worth $180,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Cerity Partners LLC raised its position in shares of Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock worth $31,689,000 after purchasing an additional 642,982 shares during the period. Shariaportfolio Inc. bought a new stake in Semler Scientific during the 3rd quarter worth approximately $3,618,000. AQR Capital Management LLC raised its holdings in Semler Scientific by 150.1% during the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after buying an additional 84,314 shares during the period. Dimensional Fund Advisors LP lifted its stake in Semler Scientific by 18.3% in the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock valued at $4,341,000 after buying an additional 19,552 shares in the last quarter. Finally, State Street Corp boosted its holdings in shares of Semler Scientific by 0.6% in the third quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after buying an additional 725 shares during the period. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Stock Down 6.3 %

Shares of SMLR stock opened at $55.24 on Wednesday. Semler Scientific, Inc. has a 12-month low of $20.88 and a 12-month high of $81.56. The firm has a fifty day moving average of $55.94 and a 200-day moving average of $38.21. The company has a market capitalization of $511.91 million, a price-to-earnings ratio of 26.95 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The company had revenue of $13.51 million during the quarter.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.